Literature DB >> 18199868

Clinical penetrance of hereditary hemochromatosis.

Bruce R Bacon, Robert S Britton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18199868     DOI： 10.1056/NEJMe078215

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  The diagnosis and management of hereditary haemochromatosis.

Authors:  Paul Clark; Laurence J Britton; Lawrie W Powell
Journal:  Clin Biochem Rev       Date:  2010-02

Review 2.  Ferritin for the clinician.

Authors:  Mary Ann Knovich; Jonathan A Storey; Lan G Coffman; Suzy V Torti; Frank M Torti
Journal:  Blood Rev       Date:  2008-10-02       Impact factor: 8.250

Review 3.  Recent advances in iron metabolism and related disorders.

Authors:  Clara Camaschella; Paolo Strati
Journal:  Intern Emerg Med       Date:  2010-04-28       Impact factor: 3.397

4.  Penetrance of NOD2/CARD15 genetic variants in the general population.

Authors:  Shiva Yazdanyar; Pia R Kamstrup; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Journal:  CMAJ       Date:  2010-04-06       Impact factor: 8.262

Review 5.  Factors influencing disease phenotype and penetrance in HFE haemochromatosis.

Authors:  J Rochette; G Le Gac; K Lassoued; C Férec; K J H Robson
Journal:  Hum Genet       Date:  2010-07-06       Impact factor: 4.132

6.  Iron homeostasis and H63D mutations in alcoholics with and without liver disease.

Authors:  Mariana Verdelho Machado; Paula Ravasco; Alexandra Martins; Maria Rosário Almeida; Maria Ermelinda Camilo; Helena Cortez-Pinto
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

Review 7.  Genetic mechanisms and modifying factors in hereditary hemochromatosis.

Authors:  Günter Weiss
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11-17       Impact factor: 46.802

8.  Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct Study.

Authors:  Clara Podmore; Karina Meidtner; Matthias B Schulze; Robert A Scott; Anna Ramond; Adam S Butterworth; Emanuele Di Angelantonio; John Danesh; Larraitz Arriola; Aurelio Barricarte; Heiner Boeing; Françoise Clavel-Chapelon; Amanda J Cross; Christina C Dahm; Guy Fagherazzi; Paul W Franks; Diana Gavrila; Sara Grioni; Marc J Gunter; Gaelle Gusto; Paula Jakszyn; Verena Katzke; Timothy J Key; Tilman Kühn; Amalia Mattiello; Peter M Nilsson; Anja Olsen; Kim Overvad; Domenico Palli; J Ramón Quirós; Olov Rolandsson; Carlotta Sacerdote; Emilio Sánchez-Cantalejo; Nadia Slimani; Ivonne Sluijs; Annemieke M W Spijkerman; Anne Tjonneland; Rosario Tumino; Daphne L van der A; Yvonne T van der Schouw; Edith J M Feskens; Nita G Forouhi; Stephen J Sharp; Elio Riboli; Claudia Langenberg; Nicholas J Wareham
Journal:  Diabetes Care       Date:  2016-02-09       Impact factor: 19.112

9.  Evidence for the high importance of co-morbid factors in HFE C282Y/H63D patients cared by phlebotomies: results from an observational prospective study.

Authors:  Philippe Saliou; Gérald Le Gac; Anne-Yvonne Mercier; Brigitte Chanu; Paul Guéguen; Marie-Christine Mérour; Isabelle Gourlaouen; Sandrine Autret; Cédric Le Maréchal; Karen Rouault; Jean-Baptiste Nousbaum; Claude Férec; Virginie Scotet
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

10.  The twin questions of personalized medicine: who are you and whom do you most resemble?

Authors:  Isaac S Kohane
Journal:  Genome Med       Date:  2009-01-20       Impact factor: 11.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.